ArticleUlusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES2026
Prognostic value of inflammatory and metabolic markers in Fournier's gangrene: a single-center retrospective analysis.
Article in Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFournier's gangrene (FG) is a rapidly progressive, life-threatening necrotizing fasciitis of the perineal and genital region. Despite advances in surgical and medical management, morbidity remains high. Early identification of disease severity and prognosis is essential for timely intervention. This study aimed to evaluate the prognostic value of routinely available inflammatory and metabolic markers-particularly C-reactive protein (CRP) and white blood cell (WBC) count-and to establish clinically applicable admission cut-off values for predicting clinical outcomes, including prolonged hospitalization and surgical burden.
methodsThis retrospective single-center study included 40 patients diagnosed with and treated for FG at Niğde Ömer Halisdemir University Training and Research Hospital between 2022 and 2025. Demographic, laboratory, and clinical data were reviewed. Laboratory parameters, including WBC count, CRP, glucose, and derived indices such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), were recorded at three time points: admission, post-first debridement, and pre-discharge. Patients were stratified according to diabetes mellitus (DM) status, antibiotic regimen, and surgical complexity. The primary outcome was prolonged hospitalization (>14 days), and the secondary outcome was the need for multiple debridements (≥3 procedures). Statistical analyses included the Friedman test for repeated measures, Spearman correlation analysis, logistic regression, and receiver operating characteristic (ROC) analysis.
resultsThe mean age was 56.8±17.9 years, and 40% of patients had DM. The most common etiology was scrotal abscess (57.5%). Serial laboratory assessment demonstrated significant reductions in WBC count (median: 13.1→8.2 ×10³/µL, p<0.001) and CRP level (median: 90.4→34.6 mg/L, p<0.001) following serial debridements. Admission CRP and WBC levels showed positive correlations with both length of hospital stay (ρ=+0.46 and +0.41, respectively) and number of debridements (ρ=+0.39 and +0.36, respectively). In multivariate regression analysis, CRP was the only independent predictor of prolonged hospitalization (odds ratio=1.07, 95% confidence interval: 1.02-1.14; p=0.009). ROC analysis identified a CRP threshold of ≥128 mg/L (area under the curve=0.86) as the optimal cut-off value for predicting prolonged hospitalization. No mortality occurred during the study period.
conclusionCRP and WBC count are practical, inexpensive, and reproducible markers of disease severity and treatment response in patients with Fournier's gangrene. Serial monitoring of these parameters may facilitate early risk stratification, guide decisions regarding repeat debridement, and support optimization of antibiotic and surgical management. Incorporation of these readily available inflammatory markers into standardized treatment protocols may improve clinical decision-making and patient outcomes in FG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.